Daniel C. Liebler

Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd.

Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.

Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.

Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO.

Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA.

American Esoteric Laboratories, Inc. provides clinical laboratory services. The firm offers esoteric testing services for hospitals and physician practices, customer connectivity, and other quality services. The company was founded by Brian C. Carr and James E. Billington in 1998 and is headquartered in Memphis, TN.

Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston.

Versant Diagnostics is a company founded in 2021 by Ven Aduana, Jim Billington, and Brian Carr. The company is based in Oak Brook, IL and has subsidiaries in the United States. Versant Diagnostics is focused on anatomic pathology, precision medicine, and the digital transformation of the industry. The company combines technological advancements in healthcare with the most skilled and diverse set of subspecialty pathologists to provide superior service for hospitals and physician practices. Versant Diagnostics aims to become the nation's largest independent physician services platform focused on anatomic pathology by consolidating the most advanced technology with the most skilled pathologists across a diverse set of specialties to provide superior, one-stop service to hospitals and independent practices. Jim Billington has been the CEO since incorporation.

Igenomix SL is a biotechnology services company. It is engaged in providing non-invasive prenatal test, carrier genetic test, preimplantation diagnosis, sperm aneuploidy test, and endometrial receptivity array services. The company was founded by Carlos Simon Valles in 1996 and is headquartered in Paterna, Spain.

Singular Bio, Inc. provides platforms for diagnostic testing in personalized medicine. The company was founded by Kalim Mir and Hywel Bowden Jones and is headquartered in San Francisco, CA.

Acuamark Diagnostics, Inc. develops blood-based screening for early cancer. The company was founded by Francis Barany and Bernard peperstraete and is headquartered in New York, NY.

AmeriPath, Inc. provides of anatomic pathology, dermatopathology and molecular diagnostic services to physicians, hospitals, clinical laboratories and surgery centers. The firm offers health plan coverage and personalized services. The company was founded in 1996 and is headquartered in Madison, NJ.

OralDNA Labs, Inc. provides salivary-based diagnostic testing services. The firm offers DNA-PCR tests for periodontal disease diagnosis and genetic susceptibility. It also develops an oral HPV test for use in assessing risks associated with oral cancer. The company was founded by Brian C. Carr, Thomas W. Nabors, Ken Clarke, Sam Daniel, Robert Walker and Russell Nabors in January 2008 and is headquartered in Eden Prairie, MN.

Trinity Investors Fund Advisors LLC (Trinity Investors) is an independent private equity firm founded in 2006 by Dan S. Meader. The firm is headquartered in Southlake, Texas.